| Literature DB >> 35655542 |
Nuno Medeiros1, Cristina Aguiar1, Paulo Pina1, Nuno Barros Lima1, João Larangeiro1, Artur Condé1.
Abstract
Introduction: Validated questionnaires are a valuable tool in medical practice. The role of septoplasty in improving patients' non-nasal symptoms and their quality of life is still controversial. The aim of this study was to determine the differences in outcome after septoplasty measured by a disease-specific questionnaire vs a general QoL questionnaire. Materials andEntities:
Keywords: Nasal Septum [MESH]; Quality of Life [MESH]; Surveys and Questionnaires [MESH]
Year: 2022 PMID: 35655542 PMCID: PMC9119657 DOI: 10.22038/IJORL.2022.59117.3076
Source DB: PubMed Journal: Iran J Otorhinolaryngol ISSN: 2251-7251
Clinical and demographic characteristics of the study population (n=50)
| Mean | SD | |
|---|---|---|
|
| 40.0 | 14.15 |
|
|
| |
|
| 33 | (66.0%) |
|
| 9 | (18.0%) |
|
| 5 | (10.0%) |
|
| 7 | (14.0%) |
Pre-operatory, post-operatory, and variation mean values for each SNOT-22 item, sorted by gender
|
|
|
|
| |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||
| 1.Need to blow nose | 2.53 | 1.59 | 2.33 | 1.29 | 0.64 | 1.65 | 1.54 | 1.42 | 1.17 | 0.57 | 0.88 | 1.73 | 0.91 | 1.40 | 0.95 | <0.001* | ||
| 2.Sneezing | 3.06 | 1.35 | 2.24 | 1.23 | 0.04* | 1.71 | 1.45 | 1.33 | 1.36 | 0.37 | 1.35 | 1.87 | 0.91 | 1.28 | 0.39 | <0.001* | ||
| 3.Runny Nose | 2.65 | 1.62 | 2.03 | 1.57 | 0.20 | 1.47 | 1.33 | 0.97 | 1.08 | 0.16 | 0.71 | 0.47 | 0.79 | 0.42 | 0.53 | <0.001* | ||
| 4.Cough | 2.41 | 1.54 | 1.42 | 1.20 | 0.02* | 1.00 | 1.32 | 0.76 | 0.94 | 0.46 | 1.41 | 1.97 | 0.67 | 1.24 | 0.17 | <0.001* | ||
| 5.Post nasal discharge | 2.59 | 1.00 | 1.94 | 1.50 | 0.12 | 1.12 | 1.41 | 1.27 | 1.44 | 0.72 | 1.47 | 1.50 | 0.67 | 1.41 | 0.07 | <0.001* | ||
| 6.Thick nasal discharge | 2.18 | 1.63 | 1.73 | 1.66 | 0.37 | 1.00 | 1.41 | 0.73 | 0.94 | 0.42 | 1.18 | 1.88 | 1.00 | 1.50 | 0.72 | <0.001* | ||
| 7.Ear fulness | 3.06 | 1.25 | 1.88 | 1.50 | 0.01* | 2.00 | 1.37 | 1.12 | 1.19 | 0.02* | 1.06 | 1.92 | 0.76 | 1.50 | 0.54 | 0.001* | ||
| 8.Dizziness | 1.94 | 1.78 | 1.15 | 1.46 | 0.10 | 0.82 | 1.13 | 0.52 | 0.94 | 0.31 | 1.12 | 1.76 | 0.64 | 1.22 | 0.32 | <0.001* | ||
| 9.Ear pain/pressure | 2.24 | 1.48 | 0.97 | 1.36 | 0.004* | 1.12 | 1.17 | 0.30 | 0.64 | 0.002* | 1.12 | 1.76 | 0.64 | 1.22 | 0.33 | 0.001* | ||
| 10.Facial pain/pressure | 2.47 | 1.66 | 1.15 | 1.35 | 0.004* | 0.88 | 1.32 | 0.52 | 0.97 | 0.27 | 1.59 | 1.94 | 0.64 | 1.14 | 0.08 | <0.001* | ||
| 11.Difficulty falling asleep | 2.47 | 1.77 | 1.82 | 1.70 | 0.21 | 1.18 | 1.33 | 0.91 | 1.38 | 0.51 | 1.29 | 1.53 | 0.88 | 1.47 | 0.36 | <0.001* | ||
| 12.Waking up at night | 2.88 | 1.69 | 2.06 | 1.71 | 0.11 | 1.82 | 1.29 | 1.21 | 1.45 | 0.15 | 1.06 | 1.56 | 0.76 | 1.41 | 0.49 | <0.001* | ||
| 13.Lack of a good night’s sleep | 3.12 | 1.65 | 2.55 | 1.62 | 0.25 | 1.94 | 1.52 | 1.27 | 1.59 | 0.16 | 1.18 | 2.16 | 1.15 | 1.89 | 0.97 | <0.001* | ||
| 14.Waking up tired | 3.41 | 1.42 | 2.15 | 1.37 | 0.004* | 2.29 | 1.49 | 1.48 | 1.52 | 0.08 | 1.12 | 1.58 | 0.67 | 1.71 | 0.37 | 0.002* | ||
| 15.Fatigue during the day | 3.29 | 1.36 | 1.97 | 1.38 | 0.002* | 2.24 | 1.48 | 1.39 | 1.17 | 0.03* | 1.06 | 1.71 | 0.58 | 1.71 | 0.35 | 0.005* | ||
| 16.Reduced productivity | 2.65 | 1.46 | 1.48 | 1.25 | 0.005* | 1.29 | 1.26 | 0.91 | 1.07 | 0.26 | 1.35 | 1.54 | 0.58 | 1.71 | 0.10 | 0.001* | ||
| 17.Reduced concentration | 2.65 | 1.54 | 1.72 | 1.46 | 0.04* | 1.41 | 1.12 | 0.91 | 1.10 | 0.14 | 1.24 | 1.99 | 0.82 | 1.42 | 0.40 | <0.001* | ||
| 18.Frustrated/restless/irritated | 3.00 | 1.58 | 1.58 | 1.44 | 0.002* | 1.53 | 1.38 | 1.06 | 1.00 | 0.17 | 1.47 | 1.91 | 0.52 | 1.42 | 0.05 | 0.001* | ||
| 19.Sad | 2.24 | 1.56 | 1.03 | 1.29 | 0.005* | 1.35 | 1.37 | 0.45 | 0.71 | 0.02* | 0.88 | 1.87 | 0.58 | 1.39 | 0.51 | 0.004* | ||
| 20.Embarassed | 1.71 | 1.83 | 0.55 | 1.23 | 0.01* | 0.65 | 1.12 | 0.18 | 0.39 | 0.11 | 1.06 | 1.78 | 0.36 | 1.32 | 0.17 | 0.009* | ||
| 21.Sense of taste/smell | 2.06 | 1.48 | 2.12 | 1.82 | 0.51 | 0.59 | 0.87 | 1.09 | 1.28 | 0.15 | 1.47 | 1.55 | 1.03 | 1.24 | 0.32 | <0.001* | ||
| 22.Blockage/congestion of nose | 3.47 | 1.42 | 3.24 | 1.32 | 0.58 | 1.59 | 1.37 | 1.21 | 1.29 | 0.35 | 1.88 | 1.41 | 2.03 | 1.42 | 0.73 | <0.001* | ||
| Total | 58.06 | 24.40 | 39.12 | 19.08 | 0.004* | 30.65 | 19.50 | 21.28 | 13.85 | 0.06 | 27.41 | 30.21 | 18.15 | 19.22 | 0.19 | <0.001* | ||
Independent t-test between genders in each section, and Stuart-Marxell test for total variation. M = mean; SD = standard deviation;p = P-value * = P<0.05
Pre-operatory, post-operatory, and variation mean values for each SF-36v2 domain, sorted by gender
|
|
|
|
| |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| 1. Physical function | 68.53 | 22.41 | 85.76 | 14.58 | 0.002* | 80.00 | 17.23 | 86.79 | 19.64 | 0.23 | 11.48 | 23.70 | 1.03 | 20.70 | 0.11 | 0.15 |
| 2. Role physical | 46.18 | 22.54 | 65.22 | 16.71 | 0.001* | 54.12 | 25.99 | 65.28 | 19.58 | 0.13 | 7.94 | 33.73 | -0.84 | 21.97 | 0.34 | 0.57 |
| 3. Bodily pain | 67.35 | 25.18 | 74.55 | 20.90 | 0.29 | 66.03 | 27.68 | 80.65 | 21.54 | 0.05 | -1.32 | 35.58 | 6.11 | 25.29 | 0.40 | 0.38 |
| 4. General Health | 73.90 | 19.04 | 76.70 | 19.28 | 0.63 | 79.04 | 26.23 | 81.40 | 25.47 | 0.76 | 5.15 | 22.99 | 4.70 | 25.82 | 0.95 | 0.17 |
| 5. Mental Health | 50.00 | 18.11 | 67.58 | 16.45 | 0.002* | 67.94 | 23.79 | 75.44 | 17.32 | 0.10 | 17.94 | 20.62 | 7.85 | 22.11 | 0.13 | 0.001* |
| 6. Role Emotional | 56.86 | 28.14 | 81.57 | 22.61 | 0.21 | 72.55 | 32.51 | 87.14 | 20.02 | 0.11 | 15.59 | 38.85 | 5.58 | 27.93 | 0.30 | 0.048* |
| 7. Social Function | 64.71 | 23.06 | 81.82 | 15.34 | 0.03* | 77.94 | 22.33 | 80.58 | 21.12 | 0.68 | 13.24 | 23.58 | -1.24 | 23.46 | 0.05 | 0.28 |
| 8. Vitality | 46.32 | 12.90 | 56.44 | 18.32 | 0.05 | 55.15 | 18.39 | 64.67 | 18.92 | 0.10 | 8.82 | 19.52 | 8.23 | 21.66 | 0.93 | 0.007* |
Independent t-test between genders in each section, and paired t-test for variation. M = mean; SD = standard deviation; p = P-value * = P<0.05
Mean values of SNOT-22 variation, divided into 5 groups according to the answer to Question 2 of SF-36, i.e., self-reported health transition. n = number of patients; M = mean; SD = standard deviation
|
| |||
|---|---|---|---|
|
| n | M | SD |
| Much better | 15 | 33,54 | 7,44 |
| Slightly better | 21 | 18,38 | 4,12 |
| Same | 11 | 14,18 | 6,45 |
| Slightly worse | 2 | 13,50 | 8,50 |
| Much worse | 1 | -7,00 | 0,00 |
Fig 1Pre- and 6-month postoperative SF-36 scores for each domain, divided into two groups according to the mean change in SNOT-22 values. Group 1(blue): change in SNOT-22 is <4.2 points. Group 2(orange): change in SNOT-22 is ≥4.2 points. PFv – Physical Function variation; RPv – Role Physical variation; BPv – Bodily Pain variation; GHv – General Health variation; MHv – Mental Health variation; REv – Role Emotional variation; SFv – Social Function variation; VTv – Vitality variaton; * P<0.05